RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in RAPT Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 98
- −8 vs. Q1 2023
- Shares held
- 34.1M
- +753.1K (+2.3%) vs. Q1 2023
- Total value
- $636.7M
- +$26.2M (+4.3%) vs. Q1 2023
- New holders
- 9
- 38 more added
- Sold out
- 17
- 33 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RAPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 106 | $1.02B |
| Q3 2025 | 65 | $428.0M |
| Q2 2025 | 50 | $135.6M |
| Q1 2025 | 92 | $160.0M |
| Q4 2024 | 91 | $199.5M |
| Q3 2024 | 94 | $59.9M |
| Q2 2024 | 103 | $97.0M |
| Q1 2024 | 122 | $287.2M |
| Q4 2023 | 109 | $869.3M |
| Q3 2023 | 96 | $577.8M |
| Q2 2023 | 98 | $636.7M |
| Q1 2023 | 106 | $610.5M |
| Q4 2022 | 95 | $634.7M |
| Q3 2022 | 98 | $721.0M |
| Q2 2022 | 85 | $542.7M |
| Q1 2022 | 85 | $616.1M |
| Q4 2021 | 99 | $1.02B |
| Q3 2021 | 106 | $817.8M |
| Q2 2021 | 109 | $846.6M |
| Q1 2021 | 78 | $468.4M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding RAPT Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Norges Bank | 0 | $0 | 0.00% | −98,100−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −59,334−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −49,366−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −39,393−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −36,935−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −33,710−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −17,509−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −13,058−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −12,799−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −7,827−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −2,567−100.0% | Sold out |
| New England Capital Financial Advisors LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −22−100.0% | Sold out |